MolPharm xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Campbell, N. R.
Right arrow Articles by Weinshilboum, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Campbell, N. R.
Right arrow Articles by Weinshilboum, R.

Human and rat liver phenol sulfotransferase: structure-activity relationships for phenolic substrates

NR Campbell, JA Van Loon, RS Sundaram, MM Ames, C Hansch and R Weinshilboum

Department of Pharmacology, Mayo Clinic, Rochester, Minnesota 55905.

Phenol sulfotransferase (PST) catalyzes the sulfate conjugation of many phenolic drugs. Human liver contains thermostable (TS) and thermolabile forms of PST. Ion exchange chromatography shows that two isozymes of TS PST (peaks I and II) are present in human liver preparations. Rat liver contains four forms of PST that can be separated by ion exchange chromatography. Quantitative structure-activity relationship (QSAR) analysis was used to study phenolic substrates for both human and rat liver PST. Thirty-six substituted phenols were tested as substrates for partially purified human liver TS PST peak I. QSAR analysis resulted in derivation of the following equation: log 1/Km = 0.92 (+/- 0.18)log P - 1.48 (+/- 0.38)MR'4 - 0.64 (+/- 0.41)MR3 + 1.04 (+/- 0.63)MR2 + 0.67(+/- 0.44) sigma- + 4.03 (+/- 0.42). In this equation Km is the Michaelis constant, P is the octanol-water partition coefficient, MR is the molar refractivity of substituents at the 2-, 3-, and 4-positions, and sigma- is the Hammett constant. Values of log 1/Km calculated with this equation were highly correlated with log 1/Km values (r = 0.950) that were observed experimentally. Nine phenols were also tested as substrates for partially purified human liver TS PST peak II. Log 1/Km values for these compounds were significantly correlated for the two isozymes of TS PST (r = 0.992, p less than 0.001). QSAR analysis was also used to derive equations that described the behavior of phenolic substrates for rat liver PST forms I and II. These equations differed substantially from the equation derived for compounds tested with human liver TS PST peak I. Therefore, the characteristics of the active sites of human liver TS PST peak I and rat liver PST forms I and II appear to differ. Application of these equations may make it possible to predict Km values of phenolic substrates for human liver TS PST and for rat liver PST forms I and II.

Volume 32, Issue 6, pp. 813-819, 12/01/1987
Copyright © 1987 by American Society for Pharmacology and Experimental Therapeutics




This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
G. R. Tulik, S. Chodavarapu, R. Edgar, L. Giannunzio, A. Langland, B. Schultz, and J. D. Beckmann
Inhibition of Bovine Phenol Sulfotransferase (bSULT1A1) by CoA Thioesters. EVIDENCE FOR POSITIVE COOPERATIVITY AND INHIBITION BY INTERACTION WITH BOTH THE NUCLEOTIDE AND PHENOL BINDING SITES
J. Biol. Chem., October 11, 2002; 277(42): 39296 - 39303.
[Abstract] [Full Text] [PDF]


Home page
Drug Metab. Dispos.Home page
J. B. Vaidyanathan and T. Walle
Glucuronidation and Sulfation of the Tea Flavonoid (-)-Epicatechin by the Human and Rat Enzymes
Drug Metab. Dispos., August 1, 2002; 30(8): 897 - 903.
[Abstract] [Full Text] [PDF]


Home page
Drug Metab. Dispos.Home page
Z.-H. Xu, T. C. Wood, A. A. Adjei, and R. M. Weinshilboum
Human 3'-Phosphoadenosine 5'-Phosphosulfate Synthetase: Radiochemical Enzymatic Assay, Biochemical Properties, and Hepatic Variation
Drug Metab. Dispos., February 1, 2001; 29(2): 172 - 178.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
R. Dajani, A. Cleasby, M. Neu, A. J. Wonacott, H. Jhoti, A. M. Hood, S. Modi, A. Hersey, J. Taskinen, R. M. Cooke, et al.
X-ray Crystal Structure of Human Dopamine Sulfotransferase, SULT1A3. MOLECULAR MODELING AND QUANTITATIVE STRUCTURE-ACTIVITY RELATIONSHIP ANALYSIS DEMONSTRATE A MOLECULAR BASIS FOR SULFOTRANSFERASE SUBSTRATE SPECIFICITY
J. Biol. Chem., December 31, 1999; 274(53): 37862 - 37868.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1987 by the American Society for Pharmacology and Experimental Therapeutics